Article Information
History
- July 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jorge Gómez Tejeda Zañudo1,2,3,*,
- Romualdo Barroso-Sousa2,3,4,*,
- Esha Jain1,2,#,
- Qingchun Jin5,
- Tianyu Li5,
- Jorge E. Buendia-Buendia1,2,#,
- Alyssa Pereslete2,
- Daniel L. Abravanel1,2,3,
- Arlindo R. Ferreira2,#,
- Eileen Wrabel2,
- Karla Helvie2,
- Melissa E. Hughes2,
- Ann H. Partridge2,3,
- Beth Overmoyer2,3,
- Nancy U. Lin2,3,
- Nabihah Tayob2,3,5,
- Sara M. Tolaney2,3,%& and
- Nikhil Wagle1,2,3,%&
- 1Cancer Program, Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
- 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- 3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
- 4Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil
- 5Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- ↵&Corresponding Authors: S. M. Tolaney, Sara_Tolaney{at}dfci.harvard.edu; N. Wagle, Nikhil_Wagle{at}dfci.harvard.edu.
↵* J. Gómez Tejeda Zañudo and R. Barroso-Sousa contributed as co-first authors of this article.